Trial Profile
Phase II trial of thioureidobutyronitrile (Kevetrin) in patients with solid tumours
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2013
Price :
$35
*
At a glance
- Drugs Thioureidobutyronitrile (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Innovation Pharmaceuticals
- 09 Dec 2013 New trial record